Inventor · Foster City, CA, US

Kapil Kumar Karki

13Patents
3h-index
52Co-inventors
55Inventor score

Filing activity: Jun 7, 2013 → May 10, 2019

Most-cited inventions

PatentTitleAreaCited byStatus
US9145441B2 Macrocyclic inhibitors of flaviviridae viruses Emerging Cross-Sectional Technologies 6 Active
US9090653B2 Macrocyclic inhibitors of flaviviridae viruses Emerging Cross-Sectional Technologies 6 Active
US9296782B2 Inhibitors of hepatitis C virus Human Necessities 4 Active
US9512175B2 Macrocyclic inhibitors of flaviviridae viruses Emerging Cross-Sectional Technologies 2 Active
US9655944B2 Inhibitors of hepatitis C virus Human Necessities 2 Active
US9873716B2 Macrocyclic inhibitors of flaviviridae viruses Emerging Cross-Sectional Technologies 2 Active
US9440991B2 Synthesis of an antiviral compound Emerging Cross-Sectional Technologies 1 Active
US10335409B2 Inhibitors of hepatitis C virus Human Necessities 1 Active
US10030033B2 Synthesis of an antiviral compound Emerging Cross-Sectional Technologies 0 Active
US10246486B2 Macrocyclic inhibitors of flaviviridae viruses Emerging Cross-Sectional Technologies 0 Active
US9617310B2 Inhibitors of hepatitis C virus Chemistry; Metallurgy 0 Active
USRE47334E1 Macrocyclic inhibitors of flaviviridae viruses General 0 Active
US10603318B2 Inhibitors of hepatitis C virus Human Necessities 0 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.